Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?

Circulation. 2012 Aug 14;126(7):e89-91. doi: 10.1161/CIRCULATIONAHA.112.110122.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angina, Stable / diagnosis*
  • Angina, Stable / drug therapy*
  • Biocompatible Materials
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / drug therapy*
  • Drug-Eluting Stents*
  • Everolimus
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Middle Aged
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives*
  • Tomography, Optical Coherence*

Substances

  • Biocompatible Materials
  • Immunosuppressive Agents
  • Everolimus
  • Sirolimus